Breast Cancer: Marta's Survivor Story
This breast cancer diagnosis at a glance
- Sex
- Female
- Treatment
- surgery, chemotherapy, radiation, hormone therapy and a clinical trial
- Outcome
- Survivorship / Completed Treatment
Treatment course, step by step
- Routine checkup in 2009 found a breast tumor at age 38; surgery confirmed malignancy
- 6 months of chemotherapy
- radiotherapy
- 5 years of hormone therapy
- clinical trial participation.
What happened, in summary
Marta was 38 in 2009 when a routine checkup found a breast tumor. She had recently returned to Spain after working in Poland, and surgery confirmed the tumor was malignant. What followed was a long and frightening 5-year path that included chemotherapy, radiotherapy, hormone therapy, and participation in a clinical trial. Marta described herself as a fearful patient who struggled with uncertainty. The shock of diagnosis, the repeated medical visits, and the tests were emotionally hard, but her brother and sister-in-law helped carry her through the earliest stage. Her friend and coworker Cristina became like a sister, someone who could cry with her but also make her laugh when there seemed to be little reason to laugh. The hardest physical period was the 6 months of chemotherapy. Marta also found support in her doctors at Hospital Gregorio Marañón, especially because they explained things and answered questions when fear took over. Music, her cat, pilates, and a small garden gave her ways to feel grounded while living alone. After completing treatment, Marta’s story became one of learning to manage fear, block certain thoughts, and build a life beyond the uncertainty of breast cancer.
Where this story comes from
This is a lay summary of an account first published by Roche España Historias. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer